&to=http://english.pravda.ru/main/2002/06/05/29832.html' target=_blank>Pfizer Inc., the world's biggest drug company, will pay $1.3 billion (Ђ1.1 billion) to Sanofi-Aventis Group to obtain full worldwide rights to the inhaled insulin the companies developed jointly and were planning to co-market. U.S. regulators are expected to rule upon the drug later this month.
Pfizer, known for blockbusters such as the cholesterol drug Lipitor, made the announcement late Thursday.
The Armed Forces of Ukraine may face new problems over the upgraded Russian unmanned aerial vehicle Lancet. Kyiv will now need to use airfields far from the line of combat contact and look for new ways to protect its aircraft